We are preparing the first study of RESKIN in patients, planned for 2027, and building the partnerships that will take it from the lab to the clinic and to the market. If you share that goal, we would like to hear from you.
Hospitals and clinicians
We are looking for clinical sites and investigators for our first-in-human study in diabetic foot ulcer, and for specialists in chronic wounds, burns and infectious diseases who want to help shape the product.
Talk to our clinical teamManufacturing and industry partners
- Medical-device manufacturing, packaging and sterilisation
- Co-development and distribution in advanced wound care
- Licensing for veterinary wound care
Research partners
- New indications: cartilage, oncology, nerve regeneration
- Sensors and wearables integrated in the membrane
- Joint applications to competitive calls
Investors
We are open to conversations with investors who want to support a deep-tech medical device on its way to the clinic.
Write to usStudents and researchers
Internships, master and PhD projects, including industrial doctorates with ICN2–CSIC.
See how to join usHow we work
We are happy to sign a non-disclosure agreement before sharing detailed data. Tell us briefly who you are and what you have in mind, and we will get back to you.
Contact usRESKIN is an investigational medical device and is not available for sale.
